
Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …

AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …

Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

Patients with inflammatory diseases tend to be better at following their treatment regimes with TNF inhibitors rather than other medicines, …

AbbVie has officially opened its expanded manufacturing plant in Sligo, Ireland. The US company has put €85 million into the …

Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …

Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …

Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …

The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …